You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Infectious mononucleosis (IM)

Showing 1 - 25 of 3,738
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Study on Infectious Mononucleosis in Munich

Completed
  • Infectious Mononucleosis
  • Epstein-Barr Virus Infections
    • Munich, Bavaria, Germany
      MRI Chonic Fatigue Center for Young People (MCFC), Children's Ho
    Aug 16, 2023

    Infectious Mononucleosis Trial in Edmonton (traditional Chinese acupuncture, standard medical care)

    Terminated
    • Infectious Mononucleosis
    • traditional Chinese acupuncture
    • standard medical care
    • Edmonton, Alberta, Canada
      University of Alberta
    Jul 7, 2022

    Epstein-Barr Virus Infection, Infectious Mononucleosis, Herpesvirus Trial run by the National Institute of Allergy and

    Not yet recruiting
    • Epstein-Barr Virus Infection
    • +2 more
    • Matrix-M1 Adjuvant
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    EBV, Epstein-Barr Virus Infection, Infectious Mononucleosis Trial run by the NIAID (EBV gp350-Ferritin Vaccine, Matrix-M1)

    Recruiting
    • EBV
    • +2 more
    • EBV gp350-Ferritin Vaccine
    • Matrix-M1
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jul 11, 2022

    Encephalomyelitis, Myalgic, Chronic Fatigue Syndrome, Chronic Fatigue Disorder Trial in Anchorage (Bupivacaine Injection)

    Recruiting
    • Encephalomyelitis, Myalgic
    • +8 more
    • Bupivacaine Injection
    • Anchorage, Alaska
      Neuroversion
    Jan 30, 2023

    HIV Indicator Diseases in Hospital and Primary Care

    Recruiting
    • HIV Infections
    • +17 more
    • Peer to peer feedback
    • HIV rapid test
    • Rotterdam, South-Holland, Netherlands
      Carlijn CCE Jordans
    Jan 26, 2022

    Point-of-Care Ultrasound in Diagnosis of Acute Infectious

    Terminated
    • Infectious Mononucleosis
    • Splenomegaly
    • Point-of-care ultrasound
    • Montreal, Quebec, Canada
    • +1 more
    Oct 4, 2020

    SARS-CoV2 COVID-19 Trial in Randwick, Adelaide, Perth (COVIGEN C19 0.8 mg ID or Placebo ID, COVIGEN C19 2.0 mg IM or Placebo IM,

    Active, not recruiting
    • SARS-CoV2 COVID-19
    • COVIGEN C19 0.8 mg ID or Placebo ID
    • +3 more
    • Randwick, New South Wales, Australia
    • +2 more
    Nov 17, 2022

    Munich ME/CFS Cohort Study

    Recruiting
    • Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (ICD-10 G93.3)
      • Munich, Bavaria, Germany
        MRI Chronic Fatigue Center for Young People (MCFC), Children's h
      Aug 16, 2023

      ME/CFS, SARS CoV 2 Infection, Fatigue Syndrome, Chronic Trial in München

      Recruiting
      • ME/CFS
      • +3 more
        • München, Germany
          München Klinik Schwabing
        Mar 20, 2023

        Influenza, Pandemic Trial in Baltimore (BW-1014: 25 µg rH5 in 20% NE - pipette - IN, BW-1014: 50 µg rH5 in 20% NE - pipette -

        Recruiting
        • Influenza, Pandemic
        • BW-1014: 25 µg rH5 in 20% NE - pipette - IN
        • +5 more
        • Baltimore, Maryland
          Center for Vaccine Development and Global Health, University of
        Jul 8, 2022

        Occurrence of Antibodies Cross-reacting With Autoantigens in

        Recruiting
        • Epstein-Barr Virus (EBV) Infection
        • Data collection: Participant characteristics (Illness course, complications of primary EBV infection and provided treatments)
        • +2 more
        • Basel, Switzerland
          University Hospital Basel, Division of Internal Medicine
        Nov 8, 2021

        HIV, Contraception, Drug-drug Interaction Trial in Eldoret (Cabotegravir/ Rilpivirine, Etonogestrel (ETG) implant, Intramuscular

        Recruiting
        • HIV Infections
        • +2 more
        • Cabotegravir/ Rilpivirine
        • +4 more
        • Eldoret, Kenya
          Academic Model Providing Access to Healthcare (AMPATH) Moi Teach
        Mar 30, 2022

        Epstein-Barr Virus Infection Trial in United States (mRNA-1195.1, mRNA-1195.2, mRNA-1189)

        Recruiting
        • Epstein-Barr Virus Infection
        • mRNA-1195.1
        • +3 more
        • Anniston, Alabama
        • +29 more
        Apr 14, 2023

        Immunodeficiency for Severe Epstein-Barr Virus Infection

        Recruiting
        • Epstein-Barr Virus Infections
        • Immunodeficiency
          • Shanghai, Shanghai, China
            Children's Hospital of Fudan University
          Mar 21, 2022

          Epstein-Barr Virus Infection Trial in United States (mRNA-1189, Placebo)

          Recruiting
          • Epstein-Barr Virus Infection
          • mRNA-1189
          • Placebo
          • Hollywood, Florida
          • +15 more
          Jul 14, 2022

          Hemophilia A Trial in Worldwide (BAY2599023 (DTX201))

          Active, not recruiting
          • Hemophilia A
          • BAY2599023 (DTX201)
          • Little Rock, Arkansas
          • +12 more
          Jan 5, 2023

          Hepatitis B, Chronic Trial in Worldwide (peginterferon alfa-2a [Pegasys])

          Completed
          Has Results
          • Hepatitis B, Chronic
          • peginterferon alfa-2a [Pegasys]
          • San Francisco, California
          • +38 more
          Oct 26, 2022

          HIV Trial in Worldwide (Oral Cabotegravir (CAB), Oral Rilpivirine (RPV), Long-Acting Injectable Cabotegravir (CAB LA))

          Recruiting
          • HIV Infections
          • Oral Cabotegravir (CAB)
          • +4 more
          • La Jolla, California
          • +30 more
          Feb 2, 2023

          Abilify Prolonged Release Aqueous Suspension for IM Injection

          Recruiting
          • Bipolar Disorder I
          • Abilify prolonged release aqueous suspension for IM injection (Aripiprazole)
          • Osaka, Japan
            Pharmacovigilance Department
          Jan 23, 2023

          HIV-1 Infection Trial in Worldwide (MK-8591A)

          Recruiting
          • HIV-1 Infection
          • Phoenix, Arizona
          • +87 more
          Aug 18, 2022

          Pharyngeal Gonococcal Infection Trial in Seattle (gentamicin 360mg IM)

          Terminated
          Has Results
          • Pharyngeal Gonococcal Infection
          • gentamicin 360mg IM
          • Seattle, Washington
            Public Health -- Seattle & King County STD Clinic
          Jul 24, 2020

          Early Detection of Epstein-Barr Virus Related Disease.

          Active, not recruiting
          • Post-transplant Lymphoproliferative Disorder
          • +8 more
            • Aarhus, Central Region Of Denmark, Denmark
              Aarhus University Hospital
            Dec 12, 2022

            SARS-CoV-2 Trial in New York (Sodium Chloride, NDV-HXP-S IN low dose, NDV-HXP-S IM low dose)

            Recruiting
            • SARS-CoV-2
            • Sodium Chloride
            • +4 more
            • New York, New York
              Icahn School of Medicine at Mount Sinai
            Jun 30, 2022

            Genetic Studies of Chronic Active Epstein-Barr Disease

            Recruiting
            • Chronic Active Epstein-Barr Virus
              • Bethesda, Maryland
                National Institutes of Health Clinical Center
              Jan 25, 2023